Cargando…
Recombinant DNA human interferon alpha 2 in advanced breast cancer: a phase 2 trial.
Effectiveness of recombinant DNA (rDNA) human interferon alpha 2 (IFN alpha 2) in advanced breast cancer was evaluated in 14 patients who had received prior endocrine and/or cytotoxic therapy. After randomization, 7 patients received IFN alpha 2 two million IU m-2 day-1, s.c., 3 times a week (schedu...
Autores principales: | Padmanabhan, N., Balkwill, F. R., Bodmer, J. G., Rubens, R. D. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1985
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1976812/ https://www.ncbi.nlm.nih.gov/pubmed/3917678 |
Ejemplares similares
-
EORTC (30885) randomised phase III study with recombinant interferon alpha and recombinant interferon alpha and gamma in patients with advanced renal cell carcinoma. The EORTC Genitourinary Group.
por: De Mulder, P. H., et al.
Publicado: (1995) -
Recombinant interferon in advanced breast cancer.
por: Nethersell, A., et al.
Publicado: (1984) -
A randomized phase II trial of interleukin 2 and interleukin 2-interferon alpha in advanced renal cancer.
por: Jayson, G. C., et al.
Publicado: (1998) -
A phase II randomised trial of 5-fluorouracil with or without interferon alpha-2a in advanced colorectal cancer.
por: Piga, A., et al.
Publicado: (1996) -
Recombinant Human Interferon Alpha 2b Prevents and Reverses Experimental Pulmonary Hypertension
por: Bauer, Eileen M., et al.
Publicado: (2014)